Athos Capital’s Amicus Therapeutics FOLD Stock Holding History

Athos Capital’s Portfolio FOLD Stock Details FOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-695,500	Closed	-$10.1M	–	42
2026 Q1	$10.1M	Buy	695,500 +95,500	+16%	+$1.37M	3.1%	10
2025 Q4	$8.54M	Buy	+600,000	New	+$5.89M	3.27%	9

Other funds holding FOLD

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Athos Capital's FOLD Position: Q2 2026 in Review

Athos Capital sold out of Amicus Therapeutics (FOLD) in Q2 2026, closing a stake of 695,500 shares — an estimated $10.1M sold.

Athos Capital first reported a position in FOLD in Q4 2025 and held it in 2 quarters. The position peaked at $10.1M in Q1 2026. 2 funds tracked by Wall St. Rank hold FOLD as of Q2 2026.

Athos Capital reported no remaining Amicus Therapeutics position as of Q2 2026 after selling out during the quarter.
Athos Capital sold 695,500 Amicus Therapeutics shares in Q2 2026, an estimated $10.1M.
Athos Capital first reported a position in Amicus Therapeutics in Q4 2025 and held it in 2 quarters.
Athos Capital's Amicus Therapeutics position peaked at $10.1M in Q1 2026.
2 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2026.

Based on Athos Capital's 13F filing for Q2 2026, filed 13 Aug 2026.